Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer

Title
Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 7, Issue 10, Pages 1594-1601
Publisher
Elsevier BV
Online
2012-09-11
DOI
10.1097/jto.0b013e3182614835

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started